By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Epigenomics today announced an exclusive agreement with DPC Lebanon for the distribution of the Epi proColon colorectal cancer test in parts of the Middle East.

Under the agreement, DPC Lebanon will distribute the test for the early detection of colorectal cancer in blood in Lebanon, the United Arab Emirates, Saudi Arabia, Qatar, Kuwait, Syria, Jordan, and Egypt.

Financial terms were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.